Search



Search only items with full text availability
Current filters:

Clear current filters  or Add more filters

View Option



Results 1-10 of 96 (Search time: 0.003 seconds).

  The Effects of Hypolipidemic Treatment on Lipoprotein-Associated Phospholipase A2 in Patients with Mixed Hyperlipidemia (Journal article)

  Effect of Ezetimibe on Markers of Oxidative Stress in Patients with Hypercholesterolemia (Journal article)

  The Effects of Hypolipidemic Regimen on Low Density Lipoprotein (Ldl) Phenotype in Patients with Mixed Hyperlipidemia (Journal article)

  The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia (Journal article)

  THE EFFECTS OF COMBINING ROSUVASTATIN WITH SARTANS OF DIFFERENT PPAR gamma ACTIVATING CAPACITY ON LOW-DENSITY LIPOPROTEIN SUBFRACTIONS AND LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A(2) (Journal article)

  Effect of Non-Statin Lipid Lowering and Anti-Obesity Drugs on LDL Subfractions in Patients with Mixed Dyslipidaemia (Journal article)

  Combining Rosuvastatin with Sartans of Different Peroxisome Proliferator-Activated Receptor-gamma Activating Capacity Is Not Associated with Different Changes in Low-Density Lipoprotein Subfractions and Plasma Lipoprotein-Associated Phospholipase A(2) (Journal article)

  The effect of simvastatin alone versus simvastatin plus ezetimibe on the concentration of small dense low-density lipoprotein cholesterol in subjects with primary hypercholesterolemia (Journal article)

  Leptospirosis is Associated with Markedly Increased Triglycerides and Small Dense Low-Density Lipoprotein and Decreased High-Density Lipoprotein (Journal article)

  Plasma Visfatin Concentration Is a Marker of an Atherogenic Metabolic Profile (Journal article)